SI1534667T1 - Muskarinski agonisti - Google Patents
Muskarinski agonistiInfo
- Publication number
- SI1534667T1 SI1534667T1 SI200331933T SI200331933T SI1534667T1 SI 1534667 T1 SI1534667 T1 SI 1534667T1 SI 200331933 T SI200331933 T SI 200331933T SI 200331933 T SI200331933 T SI 200331933T SI 1534667 T1 SI1534667 T1 SI 1534667T1
- Authority
- SI
- Slovenia
- Prior art keywords
- muscarinic agonists
- muscarinic
- agonists
- Prior art date
Links
- 239000000472 muscarinic agonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40544302P | 2002-08-22 | 2002-08-22 | |
| EP03792989A EP1534667B1 (en) | 2002-08-22 | 2003-08-12 | Muscarinic agonists |
| PCT/US2003/023260 WO2004018411A1 (en) | 2002-08-22 | 2003-08-12 | Muscarinic agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1534667T1 true SI1534667T1 (sl) | 2011-02-28 |
Family
ID=31946873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200331933T SI1534667T1 (sl) | 2002-08-22 | 2003-08-12 | Muskarinski agonisti |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7160922B2 (https=) |
| EP (1) | EP1534667B1 (https=) |
| JP (1) | JP4469280B2 (https=) |
| CN (1) | CN100554247C (https=) |
| AR (1) | AR040889A1 (https=) |
| AT (1) | ATE491683T1 (https=) |
| AU (1) | AU2003256791B2 (https=) |
| BR (1) | BR0313161A (https=) |
| CA (1) | CA2493958C (https=) |
| CY (1) | CY1111115T1 (https=) |
| DE (1) | DE60335380D1 (https=) |
| DK (1) | DK1534667T3 (https=) |
| ES (1) | ES2355213T3 (https=) |
| MX (1) | MXPA05002080A (https=) |
| PE (1) | PE20040894A1 (https=) |
| PT (1) | PT1534667E (https=) |
| SI (1) | SI1534667T1 (https=) |
| TW (1) | TW200410922A (https=) |
| WO (1) | WO2004018411A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2275095A3 (en) * | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| JP2013523679A (ja) | 2010-03-29 | 2013-06-17 | ビーエーエスエフ ソシエタス・ヨーロピア | 殺菌性イミノ誘導体 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA76492C2 (en) * | 2001-09-21 | 2006-08-15 | Lilly Co Eli | Muscarinic agonists, a pharmaceutical composition on their basis |
-
2003
- 2003-08-12 DE DE60335380T patent/DE60335380D1/de not_active Expired - Lifetime
- 2003-08-12 JP JP2004530846A patent/JP4469280B2/ja not_active Expired - Fee Related
- 2003-08-12 AU AU2003256791A patent/AU2003256791B2/en not_active Ceased
- 2003-08-12 CA CA2493958A patent/CA2493958C/en not_active Expired - Fee Related
- 2003-08-12 EP EP03792989A patent/EP1534667B1/en not_active Expired - Lifetime
- 2003-08-12 US US10/524,960 patent/US7160922B2/en not_active Expired - Fee Related
- 2003-08-12 BR BR0313161-0A patent/BR0313161A/pt not_active IP Right Cessation
- 2003-08-12 DK DK03792989.0T patent/DK1534667T3/da active
- 2003-08-12 CN CNB038192500A patent/CN100554247C/zh not_active Expired - Fee Related
- 2003-08-12 PT PT03792989T patent/PT1534667E/pt unknown
- 2003-08-12 SI SI200331933T patent/SI1534667T1/sl unknown
- 2003-08-12 WO PCT/US2003/023260 patent/WO2004018411A1/en not_active Ceased
- 2003-08-12 AT AT03792989T patent/ATE491683T1/de active
- 2003-08-12 MX MXPA05002080A patent/MXPA05002080A/es active IP Right Grant
- 2003-08-12 ES ES03792989T patent/ES2355213T3/es not_active Expired - Lifetime
- 2003-08-20 TW TW092122893A patent/TW200410922A/zh unknown
- 2003-08-20 AR AR20030103011A patent/AR040889A1/es unknown
- 2003-08-21 PE PE2003000851A patent/PE20040894A1/es not_active Application Discontinuation
-
2011
- 2011-01-19 CY CY20111100057T patent/CY1111115T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2493958A1 (en) | 2004-03-04 |
| WO2004018411A1 (en) | 2004-03-04 |
| CN1675173A (zh) | 2005-09-28 |
| BR0313161A (pt) | 2005-06-14 |
| ES2355213T3 (es) | 2011-03-23 |
| CY1111115T1 (el) | 2015-06-11 |
| JP2005536549A (ja) | 2005-12-02 |
| MXPA05002080A (es) | 2005-08-18 |
| PE20040894A1 (es) | 2004-11-25 |
| CN100554247C (zh) | 2009-10-28 |
| AR040889A1 (es) | 2005-04-20 |
| DK1534667T3 (da) | 2011-02-14 |
| DE60335380D1 (de) | 2011-01-27 |
| US7160922B2 (en) | 2007-01-09 |
| TW200410922A (en) | 2004-07-01 |
| EP1534667B1 (en) | 2010-12-15 |
| JP4469280B2 (ja) | 2010-05-26 |
| EP1534667A1 (en) | 2005-06-01 |
| AU2003256791A1 (en) | 2004-03-11 |
| ATE491683T1 (de) | 2011-01-15 |
| AU2003256791B2 (en) | 2008-12-11 |
| US20060122280A1 (en) | 2006-06-08 |
| CA2493958C (en) | 2010-11-09 |
| PT1534667E (pt) | 2011-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL163928A0 (en) | Pyridinoylpiperidines as 5-htf agonists | |
| AU5919001A (en) | Muscarinic agonists | |
| GB0206048D0 (en) | Use | |
| GB0227666D0 (en) | Use | |
| IL160751A (en) | Muscarinic agonists | |
| GB0203421D0 (en) | Composition | |
| IL173521A0 (en) | Substituted 2 - carbonylamino - 6 piperidinaminopyidines and substituted 1 - carbonylamino - 3 - piperidinaminobenzenes as 5 - th1f agonists | |
| GB0217056D0 (en) | Use | |
| GB0208608D0 (en) | Composition | |
| GB0203280D0 (en) | Anti-glycolytic composition | |
| GB0213878D0 (en) | Use | |
| EP1562593A4 (en) | Topoisomerase TARGETING AGENTS | |
| GB0206838D0 (en) | Use | |
| EP1709976A4 (en) | EMT-INDUCING MEDIUM | |
| SI1534667T1 (sl) | Muskarinski agonisti | |
| GB0230343D0 (en) | Use | |
| GB0203534D0 (en) | Muscarinic agents | |
| GB0229442D0 (en) | Use | |
| GB0303623D0 (en) | Muscarinic agents | |
| AU2358P (en) | Yasflos Sutera cordata | |
| GB0204798D0 (en) | Cycostatic agents | |
| HK1070048A (en) | Muscarinic agonists | |
| GB0224842D0 (en) | Holder | |
| GB0230038D0 (en) | Deformable-mirror holder | |
| GB0212680D0 (en) | Holder |